GeoBotanical: Cardiology Studies

1.

Use of Herbal Drugs in Cardiovascular Disease- A Review.

Researchers studied the use of phytochemicals from medicinal plants to prevent cardiovascular diseases, including lowering cholesterol and controlling diabetes. More research is needed to fully understand their effectiveness.

Cardiology Ganoderma lucidum Ginkgo biloba Gynostemma pentaphyllum

Kaur A and Kumar R (2024).; Curr Cardiol Rev.
DOI:: 10.2174/011573403X323724240830075719
PubMed:: 39229989

2.

Oroxylin A, a broad‑spectrum anticancer agent, relieves monocrotaline‑induced pulmonary arterial hypertension by inhibiting the Warburg effect in rats.

Oroxylin A (OA) inhibits glycolytic enzymes to treat liver cancer; it also decreases pulmonary arterial hypertension (PAH) in rats by reducing the Warburg effect of abnormal glucose metabolism. OA shows potential as a protective treatment for PAH.

Cancer Cardiology Scutellaria baicalensis

Wang Y et al (2024).; Mol Med Rep.
DOI:: 10.3892/mmr.2024.13319
PubMed:: 39219283

3.

Cardioprotective effect of chelidonic acid against doxorubicin-induced cardiac toxicity in rats.

Study shows CA protects against doxorubicin-induced heart damage. CA is a compound in celandine plant. Potential for new heart protection treatment.

Cardiology Chelidonium majus

Khairnar SI, Kulkarni YA and Singh K (2024).; Rev Port Cardiol.
DOI:: 10.1016/j.repc.2024.06.003
PubMed:: 39216530

4.

Ligustilide alleviates oxidative stress during renal ischemia-reperfusion injury through maintaining Sirt3-dependent mitochondrial homeostasis.

Researchers explored the potential of Ligustilide (LIG) to protect mitochondrial function and potentially ameliorate renal ischemia-reperfusion injury during transplantation. Understanding LIG's targets and mechanisms is important for improving patient outcomes.

Cardiology Immunology Angelica sinensis

Xia K et al (2024).; Phytomedicine.
DOI:: 10.1016/j.phymed.2024.155975
PubMed:: 39216302

5.

Artemisia vulgaris Extract as a Novel Therapeutic Approach for Reversing Diabetic Cardiomyopathy in a Rat Model.

Methanolic extract of [plant] shows potential in reversing cardiac remodeling in diabetic cardiomyopathy, improving heart function and reducing side effects compared to current anti-hyperglycemic therapies.

Cardiology Diabetes Artemisia vulgaris

Liza et al (2024).; Pharmaceuticals (Basel).
DOI:: 10.3390/ph17081046
PubMed:: 39204151

6.

Ethanolic Extracts of Cupressaceae Species Conifers Provide Rapid Protection against Barium Chloride-Induced Cardiac Arrhythmia.

Certain Cupressaceae species have active antiarrhythmic components, providing potential for preventing cardiac arrhythmias and reducing sudden cardiac death. Importance lies in developing new, effective and safe treatments.

Cardiology Juniperus sabina Platycladus orientalis

Zeng MT et al (2024).; Pharmaceuticals (Basel).
DOI:: 10.3390/ph17081003
PubMed:: 39204108

7.

Demonstration of the Protective Effect of Vinpocetine in Diabetic Cardiomyopathy.

Study on Vinpocetine's effects on diabetic cardiomyopathy showed it reduced heart damage, improved markers and structure. Vinpocetine may be a promising treatment for diabetic heart disease.

Cardiology Diabetes Vinca minor

Erciyes D et al (2024).; J Clin Med.
DOI:: 10.3390/jcm13164637
PubMed:: 39200779

8.

Melastoma dodecandrum lour. Protects against cerebral ischemia-reperfusion injury by ameliorating oxidative stress and endoplasmic reticulum stress.

Melastoma dodecandrum Lour. shows promise in treating cerebral ischemia-reperfusion injury. Its traditional use by the She ethnic group suggests potential efficacy in promoting blood circulation and removing blood stasis. Further research is needed to understand its therapeutic effects and mechanisms.

Cardiology Immunology Melastoma dodecandrum

Liu S et al (2024).; J Ethnopharmacol.
DOI:: 10.1016/j.jep.2024.118735
PubMed:: 39182701